Dexmedetomidine may benefit cognitive function after laparoscopic cholecystectomy in elderly patients

Experimental and Therapeutic Medicine

Volumn 5, Issue 2, 2013, Pages 489-494

  Chen, Jingjun ^a   Yan, Junqiang ^a   Han, Xueping ^b  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cognitive function; Dexmedetomidine; Laparoscopic cholecystectomy

Indexed keywords

ATROPINE; DEXMEDETOMIDINE; NEOSTIGMINE; PLACEBO; PROPOFOL; REMIFENTANIL; VECURONIUM;

ADULT; AGED; ARTICLE; CHOLECYSTECTOMY; COGNITION; COGNITIVE DEFECT; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL ANESTHESIA; HEART RATE; HUMAN; LAPAROSCOPIC SURGERY; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PATIENT ASSESSMENT; POSTOPERATIVE COGNITIVE DYSFUNCTION; POSTOPERATIVE PERIOD; PULSE OXIMETRY;

EID: 84871350211     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.811     Document Type: Article

References (46)

1. Price CC, Garvan CW and Monk TG: Type and severity of cognitive decline in older adults after noncardiac surgery. Anesthesiology 108: 8-17, 2008.
2. Bedford PD: Adverse cerebral effects of anaesthesia on old people. Lancet 269: 259-263, 1955.
3. Monk TG, Weldon BC, Garvan CW, etal: Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 108: 18-30, 2008.
4. Rasmussen LS: Postoperative cognitive dysfunction: incidence and prevention. Best Pract Res Clin Anaesthesiol 20: 315-330, 2006.
5. Zurek AA, Bridgwater EM and Orser BA: Inhibition of α5 γ-aminobutyric acid type A receptors restores recognition memory after general anesthesia. Anesth Analg 114: 845-855, 2012.
6. Callaway JK, Jones NC and Royse CF: Isoflurane induces cognitive deficits in the Morris water maze task in rats. Eur J Anaesthesiol 29: 239-245, 2012.
7. Le Freche H, Brouillette J, Fernandez-Gomez FJ, etal: Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment. Anesthesiology 116: 779-787, 2012.
8. Krenk L, Rasmussen LS, Hansen TB, Bogø S, Søballe K and Kehlet H: Delirium after fast-track hip and knee arthroplasty. Br J Anaesth 108: 607-611, 2012.
9. Kavanagh T and Buggy DJ: Can anaesthetic technique effect postoperative outcome? Curr Opin Anaesthesiol 25: 185-198, 2012.
10. Denis R, Letourneau JE and Londorf D: Reliability and validity of psychomotor tests as measures of recovery from isoflurane or enflurane anesthesia in a day-care surgery unit. Anesth Analg 63: 653-656, 1984.
11. Tzabar Y, Asbury AJ and Millar K: Cognitive failures after general anaesthesia for day-case surgery. Br J Anaesth 76: 194-197, 1996.
12. Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP and Charlson ME: Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA 274: 44-50, 1995.
13. Rasmussen LS, Johnson T, Kuipers HM, etal: Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand 47: 260-266, 2003.
14. Bhana N, Goa KL and McClellan KJ: Dexmedetomidine. Drugs59: 263-268; discussion 269-270, 2000.
15. Guler G, Akin A, Tosun Z, Eskitascoglu E, Mizrak A and BoyaciA: Single-dose dexmedetomidine attenuates airway and circulatory reflexes during extubation. Acta Anaesthesiol Scand49: 1088-1091, 2005.
16. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG and Amin D: Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 83: 372-380, 1999.
17. Jaakola ML, Salonen M, Lehtinen R and Scheinin H: The analgesic action of dexmedetomidine-a novel alpha 2-adrenoceptor agonist-in healthy volunteers. Pain 46: 281-285, 1991.
18. Candiotti KA, Bergese SD, Bokesch PM, Feldman MA, Wisemandle W and Bekker AY; MAC Study Group: Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg 110: 47-56, 2010.
19. Cooper L, Candiotti K, Gallagher C, Grenier E, Arheart KL and Barron ME: A randomized, controlled trial on dexmedetomidine for providing adequate sedation and hemodynamic control for awake, diagnostic transesophageal echocardiography. JCardiothorac Vasc Anesth 25: 233-237, 2011.
20. Xu Y, Yan J, Zhou P, etal: Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 97: 1-13, 2012.
21. Coull JT: Pharmacological manipulations of the alpha 2-noradrenergic system. Effects on cognition. Drugs Aging 5: 116-126, 1994.
22. Milstein JA, Lehmann O, Theobald DE, Dalley JW and Robbins TW: Selective depletion of cortical noradrenaline by anti-dopamine beta-hydroxylase-saporin impairs attentional function and enhances the effects of guanfacine in the rat. Psychopharmacology (Berl) 190: 51-63, 2007.
23. Galeotti N, Bartolini A and Ghelardini C: Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. Behav Brain Res 153: 409-417, 2004.
24. Folstein MF, Folstein SE and McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975.
25. Rasmussen LS; ISPOCD2 Investigators: Post-operative cognitive dysfunction in the elderly. Acta Anaesthesiol Scand 49: 1573, 2005.
26. Rasmussen LS and Siersma VD; ISPOCD Group: Postoperative cognitive dysfunction: true deterioration versus random variation. Acta Anaesthesiol Scand 48: 1137-1143, 2004.
27. Ancelin ML, de Roquefeuil G, Scali J, etal: Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. J Alzheimers Dis 22 (Suppl 3): 105-113, 2010.
28. Jin F and Chung F: Minimizing perioperative adverse events in the elderly. Br J Anaesth 87: 608-624, 2001.
29. Ehara T, Ogawa Y, Kato J, Aoki K, Ogawa S and Iwasaki K: The effect of dexmedetomidine on arterial-cardiac baroreflex function assessed by spectral and transfer function analysis. JAnesth 26: 483-489, 2012.
30. Dodds TM, Stone JG, Coromilas J, Weinberger M and Levy DG: Prophylactic nitroglycerin infusion during noncardiac surgery does not reduce perioperative ischemia. Anesth Analg 76: 705-713, 1993.
31. Iirola T, Vilo S, Manner T, etal: Bioavailability of dexmedetomidine after intranasal administration. Eur J Clin Pharmacol 67: 825-831, 2011.
32. Honkavaara JM, Restitutti F, Raekallio MR, Kuusela EK and Vainio OM: The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs. J Vet Pharmacol Ther 34: 332-337, 2011.
33. Khan ZP, Ferguson CN and Jones RM: alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia 54: 146-165, 1999.
34. Martin E, Ramsay G, Mantz J and Sum-Ping ST: The role of the alpha2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit. J Intensive Care Med 18: 29-41, 2003.
35. Ben-Abraham R, Ogorek D and Weinbroum AA: Dexmedetomidine: a promising agent for anesthesia and perioperative care. Isr Med Assoc J 2: 793-796, 2000.
36. Lawrence CJ and De Lange S: Effects of a single pre-operative dexmedetomidine dose on isoflurane requirements and peri-operative haemodynamic stability. Anaesthesia 52: 736-744, 1997.
37. Lawrence CJ, Prinzen FW and de Lange S: Hemodynamic and coronary vascular effects of dexmedetomidine in the anesthetized goat. Acta Anaesthesiol Scand 41: 830-836, 1997.
38. Yildiz M, Tavlan A, Tuncer S, Reisli R, Yosunkaya A and Otelcioglu S: Effect of dexmedetomidine on haemodynamic responses to laryngoscopy and intubation: perioperative haemodynamics and anaesthetic requirements. Drugs R D 7: 43-52, 2006.
39. Kang WS, Kim SY, Son JC, etal: The effect of dexmedetomidine on the adjuvant propofol requirement and intraoperative hemodynamics during remifentanil-based anesthesia. Korean J Anesthesiol 62: 113-118, 2012.
40. Sato K, Kimura T, Nishikawa T, Tobe Y and Masaki Y: Neuroprotective effects of a combination of dexmedetomidine and hypothermia after incomplete cerebral ischemia in rats. Acta Anaesthesiol Scand 54: 377-382, 2010.
41. Sanders RD, Xu J, Shu Y, etal: Dexmedetomidine attenuates isoflurane-induced neurocognitive impairment in neonatal rats. Anesthesiology 110: 1077-1085, 2009.
42. Goyagi T, Nishikawa T, Tobe Y and Masaki Y: The combined neuroprotective effects of lidocaine and dexmedetomidine after transient forebrain ischemia in rats. Acta Anaesthesiol Scand 53: 1176-1183, 2009.
43. Kuhmonen J, Haapalinna A and Sivenius J: Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 108: 261-271, 2001.
44. Kuhmonen J, Pokorný J, Miettinen R, etal: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 87: 371-377, 1997.
45. Moller JT, Cluitmans P, Rasmussen LS, etal: Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study. ISPOCD investigators. International Study of Post-Operative Cognitive Dysfunction. Lancet 351: 857-861, 1998.
46. Rasmussen LS, Steentoft A, Rasmussen H, Kristensen PA and Moller JT: Benzodiazepines and postoperative cognitive dysfunction in the elderly. ISPOCD Group. International Study of Postoperative Cognitive Dysfunction. Br J Anaesth 83: 585-589, 1999.